help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on June 8, 2006, doi:10.1165/rcmb.2005-0282OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0282OCv1
35/5/559    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, P. E.
Right arrow Articles by Peebles, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, P. E.
Right arrow Articles by Peebles, R. S., Jr.
American Journal of Respiratory Cell and Molecular Biology. Vol. 35, pp. 559-564, 2006
© 2006 American Thoracic Society
DOI: 10.1165/rcmb.2005-0282OC

Respiratory Syncytial Virus Infection Reduces beta2-Adrenergic Responses in Human Airway Smooth Muscle

Paul E. Moore, Gary Cunningham, Mark M. Calder, Anthony D. DeMatteo, Jr., Mark E. Peeples, Marshall L. Summar and R. Stokes Peebles, Jr.

Departments of Pediatrics and Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; and Department of Pediatrics, The Ohio State University, Columbus, Ohio

Correspondence and requests for reprints should be addressed to Dr. Paul E. Moore, Vanderbilt University School of Medicine, 2200 Children's Way, 11215 Doctor's Office Tower, Nashville, TN 37232–9500. E-mail: paul.moore{at}vanderbilt.edu

Although respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract illness in infants, the effect of RSV on human airway smooth muscle (HASM) has not been studied. We hypothesized that RSV has direct effects on cAMP formation and beta2-adrenergic receptor (ADRB2) density and that ADRB2 haplotype influences this response. A recombinant green-fluorescent protein (rg) expressing RSV was used to determine whether RSV could infect cultured HASM. Influence of RSV infection on beta2-adrenergic responsiveness was determined by measuring differences in isoproterenol (ISO)-induced cyclic AMP (cAMP) formation, ADRB2 density, and Gi expression in HASM cells challenged with RSV, with ultraviolet-inactivated RSV, and with mock infection. The rgRSV efficiently infected cultured HASM cells. ISO-induced cAMP formation was significantly reduced in cells infected with RSV, compared with mock-infected and ultraviolet-inactivated RSV, in a time- and concentration-dependent manner. Forskolin-induced cAMP formation and Gi expression were not altered in cells infected with RSV, suggesting that the influence of RSV on beta2-adrenergic relaxation was upstream of cAMP formation. ADRB2 density was reduced in cells infected with RSV, compared with mock infection, and the Arg16Gln27 ADRB2 haplotype was associated with decreased ISO-induced cAMP formation (P < 0.05) and with decreased ADRB2 density at baseline (P < 0.05). The implications of these results are that limitations of beta2-agonists in the treatment of any airway obstruction associated with RSV infection may be related to direct effects of RSV on HASM, and ADRB2 genotype may predict beta2-adrenergic responses.

Key Words: beta2-adrenergic receptor • haplotype • human airway smooth muscle • isoproterenol • respiratory syncytial virus




This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Z. P. Traylor, E. N. Z. Yu, and I. C. Davis
Respiratory syncytial virus induces airway insensitivity to {beta}-agonists in BALB/c mice
Am J Physiol Lung Cell Mol Physiol, March 1, 2010; 298(3): L437 - L445.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. E. Moore
Exploration of the {beta}2-adrenergic receptor regulatory regions: the next step in the holy grail of asthma pharmacogenetics research
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L187 - L189.
[Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
I. C. Davis, E. R. Lazarowski, F.-P. Chen, J. M. Hickman-Davis, W. M. Sullender, and S. Matalon
Post-Infection A77-1726 Blocks Pathophysiologic Sequelae of Respiratory Syncytial Virus Infection
Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 379 - 386.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. C. Davis, A. Xu, Z. Gao, J. M. Hickman-Davis, P. Factor, W. M. Sullender, and S. Matalon
Respiratory syncytial virus induces insensitivity to beta-adrenergic agonists in mouse lung epithelium in vivo
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L281 - L289.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Clerici
A new mechanism for respiratory syncytial virus-induced beta2-adrenergic receptor insensitivity
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L279 - L280.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2006 American Thoracic Society. 		  Red In Translatin